Create Health
21 – 40 of 1002
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Spatial tumor immune microenvironment phenotypes in ovarian cancer
(
- Contribution to journal › Article
-
Mark
In vivo dendritic cell reprogramming for cancer immunotherapy
2024) In Science (New York, N.Y.)(
- Contribution to journal › Article
-
Mark
Occupational second-hand smoke exposure : A comparative shotgun proteomics study on nasal epithelia from healthy restaurant workers
(
- Contribution to journal › Article
- 2023
-
Mark
Preface
2023)(
- Chapter in Book/Report/Conference proceeding › Foreword/Postscript
-
Mark
IGHV allele similarity clustering improves genotype inference from adaptive immune receptor repertoire sequencing data
(
- Contribution to journal › Article
-
Mark
Exploring Spatial Heterogeneity of Immune Cells in Nasopharyngeal Cancer
(
- Contribution to journal › Article
-
Mark
Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy–treated mantle cell lymphoma
(
- Contribution to journal › Article
-
Mark
Metabolomic and transcriptomic analyses identify external conditions and key genes underlying high levels of toxic glycoalkaloids in tubers of stress-sensitive potato cultivars
(
- Contribution to journal › Article
-
Mark
Nordic microalgae produce biostimulant for the germination of tomato and barley seeds
(
- Contribution to journal › Article
-
Mark
Comparative gut proteomics study revealing adaptive physiology of Eurasian spruce bark beetle, Ips typographus (Coleoptera: Scolytinae)
(
- Contribution to journal › Article
-
Mark
Selection, characterization and in vivo evaluation of novel CD44v6-targeting antibodies for targeted molecular radiotherapy
(
- Contribution to journal › Article
-
Mark
Targeted spatial proteomic analysis of CD8+ T- and myeloid cells in tonsillar cancer
(
- Contribution to journal › Article
-
Mark
ATOR-1017 (evunzekibart), an Fc-gamma receptor conditional 4-1BB agonist designed for optimal safety and efficacy, activates exhausted T cells in combination with anti-PD-1
(
- Contribution to journal › Article
-
Mark
Design, structure and plasma binding of ancestral β-CoV scaffold antigens
(
- Contribution to journal › Article
-
Mark
Early Pharmacodynamic Changes Measured Using RNA Sequencing of Peripheral Blood from Patients in a Phase I Study with Mitazalimab, a Potent CD40 Agonistic Monoclonal Antibody
(
- Contribution to journal › Article
-
Mark
Preface
2023) 2.(
- Chapter in Book/Report/Conference proceeding › Foreword/Postscript
-
Mark
Preface
2023)(
- Chapter in Book/Report/Conference proceeding › Foreword/Postscript
-
Mark
Protein Biomarker Signatures in Precision Diagnostics of Cancer
2023) p.487-505(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Protective non-neutralizing mAbs Ab94 and Ab81 retain high-affinity and potent Fc-mediated function against SARS-CoV-2 variants from Omicron to XBB1.5
2023)(
- Working paper/Preprint › Preprint in preprint archive
-
Mark
An mTRAN-mRNA interaction mediates mitochondrial translation initiation in plants
(
- Contribution to journal › Article